Prolia (denosumab) 60 mg/mL, 1 pre-filled syringe, Amgen Prolia (denosumab) is used for approved osteoporosis indications. International medicine delivery within 4-5 days with storage conditions maintained. Payment on delivery. Order at +380996042415 via Viber or WhatsApp.
- We can ship by mail to any European country with a delivery time of 8-10 days. Only medications that do not require refrigeration possible shipping. Shipping costs are 40-50 euro, depending on the destination country.
Delivery time
- Originator medicines: 8-10 days
- Generic medicines: 8-10 days
- Bank transfer to the settlement account after receiving the order
Indications
Treatment of osteoporosis in postmenopausal women and men at increased risk of fractures. In postmenopausal women, the drug Prolia®significantly reduces the risk of vertebral fractures, non-vertebral fractures, and hip fractures.
Treatment of bone loss in men at increased risk of fractures receiving hormone-suppressive therapy for prostate cancer (see section "Pharmacodynamics"). In men with prostate cancer receiving hormone-suppressive therapy, Prolia®significantly reduces the risk of vertebral fractures.
Treatment of bone loss associated with long-term systemic glucocorticoid therapy in adult patients at increased risk of fractures
Dozuvannya
Recommended dose denosumab - one subcutaneous injection of 60 mg of the drug once every 6 months, which is injected into the thigh, abdomen or outer surface of the shoulder.
- Trade name:Prolia
- Chemical name:Denosumab
- Dosage:60 mg
- Quantity:1
- Dosage form:Syringe
